Merck Teams Up With Sinopharm On Vaccines As It Gears Up For Gardasil Approval In China

HONG KONG - U.S.-based Merck and China's Sinopharm plan to work together to develop vaccines in China under a preliminary deal that could ultimately see Sinopharm marketing more of the pharmaceutical giant's products in Asia's most populous nation